SAN DIEGO, May 2, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced the Company is a
leading sponsor of EPOSNA 2017, the combined meeting of the EPOS
(European Paediatric Orthopaedic Society) and POSNA (Pediatric
Orthopaedic Society of North
America) annual meetings, held this week in Barcelona, Spain. NuVasive also announced the
launch of a monthly podcast, MAGEC Matters, featuring
interviews with the leading surgeons in pediatric deformity and
sharing clinical insights on the treatment of early-onset
scoliosis.
"At NuVasive, we are not only passionate about the world-class
innovation we are bringing to market to help improve pediatric
spinal deformity, but we're also passionate about the education and
research that is necessary to provide surgeons with the information
they need to advance the care options available to pediatric
patients," said Jason Hannon,
NuVasive's president and chief operating officer. "We've made
tremendous investments in building a comprehensive pediatric
deformity portfolio, with our MAGEC® system,
RELINE® posterior fixation platform and
PRECICE® limb lengthening system. By supporting events
such as EPOSNA, we are able to connect surgeons from around the
world and help improve the lives of children."
EPOSNA is the world's largest pediatric orthopaedic scientific
meeting with over 1,300 abstracts submitted. The Company's
sponsorship of the event includes exhibit floor presence featuring
pediatric spine and orthopedic solutions and the following
workshops:
- "MAGEC Masters Roundtable: Key Principles for Challenging
Applications"; Wednesday, May 3,
2017 from 12:45 – 13:35 p.m.
(CEST); Featuring Michael Vitale, M.D., Peter Sturm, M.D., Burt Yaszay, M.D. and
Jeff Sawyer, M.D.
- "So You're Not Sure You Can Do Limb Lengthening";
Thursday, May 4, 2017 from 12:45 –
13:35 p.m. (CEST); Featuring Christof
Radler, M.D. and Frank Schiedel,
M.D.
As a key education initiative for the pediatric spinal deformity
community, NuVasive also announced the launch of a monthly podcast
series, MAGEC Matters, featuring interviews with leading
surgeons in pediatric deformity discussing tips for the treatment
of early-onset scoliosis, which is now available on iTunes,
SoundCloud and other leading podcast platforms.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is a world leader in minimally invasive,
procedurally-integrated spine solutions. From complex spinal
deformity to degenerative spinal conditions, NuVasive is
transforming spine surgery with innovative technologies designed to
deliver reproducible and clinically proven surgical outcomes.
NuVasive's highly differentiated, procedurally-integrated solutions
include access instruments, implantable hardware and software
systems for surgical planning and reconciliation technology that
centers on achieving the global alignment of the spine. With
$962 million in revenues (2016),
NuVasive has an approximate 2,300 person workforce in more than 40
countries around the world. For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you
that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could
cause NuVasive's results to
differ materially from historical results or those expressed or
implied by such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products
(including the iGA™ platform), the Company's ability to effectually
manage inventory as it continues to release new products, its
ability to recruit and retain management and key personnel, and the
other risks and uncertainties described
in NuVasive's news releases
and periodic filings with the Securities and
Exchange Commission. NuVasive's public filings
with the Securities and Exchange
Commission are available
at www.sec.gov. NuVasive assumes
no obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-announces-sponsorship-of-eposna-2017-and-launches-new-monthly-pediatric-spinal-deformity-podcast-300449960.html
SOURCE NuVasive, Inc.